img

Global Polymerase Chain Reaction (PCR) Technologies Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Service & Software

Publisher : GRD Survey | Format : PDF

Global Polymerase Chain Reaction (PCR) Technologies Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Polymerase Chain Reaction (PCR) Technologies market is estimated at 7030 million US$ in 2021 and is expected to 9190 million US$ by the end of 2028, growing at a CAGR of 3.9% in the forecast period from 2022 to 2028.

This report studies the Polymerase Chain Reaction (PCR) Technologies market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Polymerase Chain Reaction (PCR) Technologies in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Digital Polymerase Chain Reaction
Real Time Q-Polymerase Chain Reaction
Standard Polymerase Chain Reaction
Assembly Polymerase Chain Reaction
Inverse Polymerase Chain Reaction
Multiplex Polymerase Chain Reaction
Hot Start Polymerase Chain Reaction

Market Snapshot, By Application
Biotechnology
Drug Discovery
Clinical Diagnostics

Main Market Players Analyzed in this report, including
Thermo Fisher Scientific
Sigma-Aldrich
Roche
Maxim Biotech
Kapa Biosystems
GE Healthcare
Becton
Agilent Technologies
Abbott Laboratories

The study objectives of this report are
To study and analyze the global Polymerase Chain Reaction (PCR) Technologies market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Polymerase Chain Reaction (PCR) Technologies market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Polymerase Chain Reaction (PCR) Technologies manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Polymerase Chain Reaction (PCR) Technologies market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Polymerase Chain Reaction (PCR) Technologies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Polymerase Chain Reaction (PCR) Technologies are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global Polymerase Chain Reaction (PCR) Technologies Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Polymerase Chain Reaction (PCR) Technologies Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Polymerase Chain Reaction (PCR) Technologies Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Polymerase Chain Reaction (PCR) Technologies

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Biotechnology
3.2.2 Major Buyers in Drug Discovery

4 Market Segment: by Type
4.1 Polymerase Chain Reaction (PCR) Technologies Type Introduction
4.1.1 Digital Polymerase Chain Reaction
4.1.2 Real Time Q-Polymerase Chain Reaction
4.1.3 Standard Polymerase Chain Reaction
4.1.4 Assembly Polymerase Chain Reaction
4.1.5 Inverse Polymerase Chain Reaction
4.1.6 Multiplex Polymerase Chain Reaction
4.1.7 Hot Start Polymerase Chain Reaction
4.2 Global Polymerase Chain Reaction (PCR) Technologies Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Polymerase Chain Reaction (PCR) Technologies Type Introduction
5.1.1 Biotechnology
5.1.2 Drug Discovery
5.1.3 Clinical Diagnostics
5.2 Global Polymerase Chain Reaction (PCR) Technologies Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Polymerase Chain Reaction (PCR) Technologies Market by Region
6.2 North America Polymerase Chain Reaction (PCR) Technologies Market 2016-2021
6.3 Europe Polymerase Chain Reaction (PCR) Technologies Market 2016-2021
6.4 Asia Pacific Polymerase Chain Reaction (PCR) Technologies Market 2016-2021
6.5 South America Polymerase Chain Reaction (PCR) Technologies Market 2016-2021
6.6 Middle East and Africa Polymerase Chain Reaction (PCR) Technologies Market 2016-2021

7 North America
7.1 North America Polymerase Chain Reaction (PCR) Technologies Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Polymerase Chain Reaction (PCR) Technologies Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Polymerase Chain Reaction (PCR) Technologies Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Polymerase Chain Reaction (PCR) Technologies Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Polymerase Chain Reaction (PCR) Technologies Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Information
12.1.2 Thermo Fisher Scientific Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.1.3 Thermo Fisher Scientific Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.1.4 Thermo Fisher Scientific Key Development
12.2 Sigma-Aldrich
12.2.1 Sigma-Aldrich Company Information
12.2.2 Sigma-Aldrich Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.2.3 Sigma-Aldrich Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.2.4 Sigma-Aldrich Key Development
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.3.3 Roche Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.3.4 Roche Key Development
12.4 Maxim Biotech
12.4.1 Maxim Biotech Company Information
12.4.2 Maxim Biotech Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.4.3 Maxim Biotech Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.4.4 Maxim Biotech Key Development
12.5 Kapa Biosystems
12.5.1 Kapa Biosystems Company Information
12.5.2 Kapa Biosystems Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.5.3 Kapa Biosystems Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.5.4 Kapa Biosystems Key Development
12.6 GE Healthcare
12.6.1 GE Healthcare Company Information
12.6.2 GE Healthcare Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.6.3 GE Healthcare Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.6.4 GE Healthcare Key Development
12.7 Becton
12.7.1 Becton Company Information
12.7.2 Becton Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.7.3 Becton Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.7.4 GE Healthcare Key Development
12.9 Abbott Laboratories
12.9.1 Abbott Laboratories Company Information
12.9.2 Abbott Laboratories Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.9.3 Abbott Laboratories Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.9.4 Abbott Laboratories Key Development
12.8.1 Agilent Technologies Company Information
12.8.2 Agilent Technologies Polymerase Chain Reaction (PCR) Technologies Product Portfolio, Specification and Application
12.8.3 Agilent Technologies Polymerase Chain Reaction (PCR) Technologies Revenue and Gross Margin (2019-2021)
12.8.4 Agilent Technologies Key Development

13 Global Polymerase Chain Reaction (PCR) Technologies Market Forecast by Region by Type and by Application
13.1 Global Polymerase Chain Reaction (PCR) Technologies Revenue Forecast 2022-2027
13.2 Global Polymerase Chain Reaction (PCR) Technologies Forecast by Regions
13.3 Global Polymerase Chain Reaction (PCR) Technologies Forecast by Type
13.4 Global Polymerase Chain Reaction (PCR) Technologies Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer